top of page

DIAGNOSTICS
        ON THE SPOT

Rapid, affordable, powerful, AI-based diagnostic tests
right on your smartphone

Rapid and affordable lab-quality testing at the point-of-care and at home

The NanoSpot.ai rapid test combines a unique agglutination-based assay with an artificial-intelligence powered mobile application to deliver rapid, semi- quantitative, and instrument-free diagnostic results on site, in a point-of-care (POC) setting, and in an at-home testing environment.

Ultra-Fast

Sample to answer in under 3 minutes

Accurate

Results you can count on

Affordable

Enables insight in any environment

Semi-Quantitative

Results calibrated to international standards

Instrument-Free

Transforming cell phones into diagnostic instruments

Diagnostics in the palm of your hand

No need for expensive equipment. The combination of a special test card, integrated test calibrators, a user-friendly app, and artificial intelligence-based analysis allows for objective, semi-quantitative rapid testing results on your phone.

Nanospot.ai Draft 3
Play Video

Get results in 3 minutes and 5 easy steps

Explore our innovative testing platform

The NanoSpot.ai rapid immunoassay testing platform can be used for serology testing or blood grouping. Results can be stored on the phone, shared via email or text, saved as a pdf, printed, or integrated into Electronic Medical Records systems.

image.png

Blood Typing Test

The NanoSpot.ai rapid ABO/RhD Blood Typing Test allows safe, easy, accurate, and fast determination of your blood type and Rh factor on-site and at home. 

Screen Shot 2023-02-11 at 2.07_edited.png

SARS-CoV-2 antibody test

The NanoSpot.ai rapid SARS-CoV-2 Total Antibody test is a semi-quantitative Covid-19 antibody test that provides fast, accurate and semi-quantitative antibody level results. 

The NanoSpot.ai SARS-CoV-2 Total Antibody Test has been CE Marked.

The NanoSpot.ai SARS-CoV-2 Total Antibody Test has not been FDA cleared, approved, or authorized under an emergency use authorization.

The NanoSpot.ai Website may depict certain of our future planned care offerings which are subject to completion of development and may require regulatory authorization, clearance, or approval before they can be commercialized.

Screen Shot 2023-02-11 at 2.35.48 PM.png

Discover NanoSpot.ai Insights, our new global medical database

The NanoSpot.ai Insights Global Medical Database is currently being developed. It is aimed at providing global healthcare insights for healthcare providers, epidemiologists, public health officials, researchers and anyone else who is interested in global health data.

/ Latest News

bottom of page